Literature DB >> 24360166

NF-κB suppresses the expression of ATP-binding cassette transporter A1/G1 by regulating SREBP-2 and miR-33a in mice.

Guo-Jun Zhao1, Shi-Lin Tang2, Yun-Cheng Lv2, Xin-Ping Ouyang2, Ping-Ping He2, Feng Yao2, Yan-Yan Tang2, Min Zhang2, Ya-Ling Tang2, Deng-Pei Tang3, Francisco S Cayabyab4, Guo-Ping Tian5, Chao-Ke Tang6.   

Abstract

Entities:  

Keywords:  ABCA1; ABCG1; NF-κB; SREBP-2; miR-33a

Mesh:

Substances:

Year:  2013        PMID: 24360166     DOI: 10.1016/j.ijcard.2013.11.093

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  12 in total

1.  Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-кB/ZNF202 pathway in THP-1 macrophages.

Authors:  Liangjie Peng; Zizhen Zhang; Min Zhang; Xiaohua Yu; Feng Yao; Yulin Tan; Dan Liu; Duo Gong; Huang Chong; Xiaoyan Liu; Xilong Zheng; Guoping Tian; Chaoke Tang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-27       Impact factor: 3.848

2.  MicroRNA-33 Regulates the Innate Immune Response via ATP Binding Cassette Transporter-mediated Remodeling of Membrane Microdomains.

Authors:  Lihua Lai; Kathleen M Azzam; Wan-Chi Lin; Prashant Rai; Julie M Lowe; Kristin A Gabor; Jennifer H Madenspacher; Jim J Aloor; John S Parks; Anders M Näär; Michael B Fessler
Journal:  J Biol Chem       Date:  2016-07-28       Impact factor: 5.157

3.  ABCA1, ABCG1, and Cholesterol Homeostasis.

Authors:  Xiao-Hua Yu; Chao-Ke Tang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Ethanol extract of Zhongtian hawthorn lowers serum cholesterol in mice by inhibiting transcription of 3-hydroxy-3-methylglutaryl-CoA reductase via nuclear factor-kappa B signal pathway.

Authors:  Hai-Jie Hu; Xue-Gang Luo; Qing-Qing Dong; Ai Mu; Guo-Long Shi; Qiu-Tong Wang; Xiao-Ying Chen; Hao Zhou; Tong-Cun Zhang; Li-Wen Pan
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-28

Review 5.  miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches.

Authors:  Nathan L Price; Leigh Goedeke; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  EMBO Mol Med       Date:  2021-05-03       Impact factor: 12.137

6.  MicroRNA-33/33* inhibit the activation of MAVS through AMPK in antiviral innate immunity.

Authors:  Danhui Liu; Qinchun Tan; Jie Zhu; Yuanyuan Zhang; Yue Xue; Yinjing Song; Yang Liu; Qingqing Wang; Lihua Lai
Journal:  Cell Mol Immunol       Date:  2019-11-25       Impact factor: 22.096

7.  Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism.

Authors:  Mireille Ouimet; Stefan Koster; Erik Sakowski; Bhama Ramkhelawon; Coen van Solingen; Scott Oldebeken; Denuja Karunakaran; Cynthia Portal-Celhay; Frederick J Sheedy; Tathagat Dutta Ray; Katharine Cecchini; Philip D Zamore; Katey J Rayner; Yves L Marcel; Jennifer A Philips; Kathryn J Moore
Journal:  Nat Immunol       Date:  2016-04-18       Impact factor: 25.606

8.  Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet.

Authors:  Fei Luo; Yuan Guo; Gui-Yun Ruan; Jun-Ke Long; Xi-Long Zheng; Qin Xia; Shui-Ping Zhao; Dao-Quan Peng; Zhen-Fei Fang; Xiang-Ping Li
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

9.  IRAK1 mediates TLR4-induced ABCA1 downregulation and lipid accumulation in VSMCs.

Authors:  L Guo; C-H Chen; L-L Zhang; X-J Cao; Q-L Ma; P Deng; G Zhu; C-Y Gao; B-H Li; Y Pi; Y Liu; Z-C Hu; L Zhang; Z-P Yu; Z Zhou; J-C Li
Journal:  Cell Death Dis       Date:  2015-10-29       Impact factor: 8.469

10.  Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis.

Authors:  Yun-Cheng Lv; Yan-Yan Tang; Ping Zhang; Wei Wan; Feng Yao; Ping-Ping He; Wei Xie; Zhong-Cheng Mo; Jin-Feng Shi; Jian-Feng Wu; Juan Peng; Dan Liu; Francisco S Cayabyab; Xi-Long Zheng; Xiang-Yang Tang; Xin-Ping Ouyang; Chao-Ke Tang
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.